EFFICACY OF TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH A 'NARROW' FIBROUS ANNULUS
https://doi.org/10.17802/2306-1278-2026-15-2-165-179
Abstract
Highlights
- Transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus and borderline mitral valve area demonstrated high technical success and a low rate of complications. In most cases, a significant reduction of mitral regurgitation to ≤ grade 2 was achieved while maintaining low transmitral gradients, thereby minimizing the risk of iatrogenic mitral stenosis. One-year follow-up outcomes confirmed the durability of both hemodynamic and clinical benefits in the majority of patients. These findings support the feasibility and safety of transcatheter mitral valve repair in carefully selected patients with anatomically «small» mitral valves when performed in specialized high-volume expert centers.
Aim. To evaluate the efficacy and safety of transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus and initially limited mitral valve area.
Methods. The study included 46 patients with severe mitral regurgitation (grade 3–4) who underwent M-TEER at the A.N. Bakulev National Medical Research Center for Cardiovascular Surgery. The mean age was 68.9 ± 8 years. Most patients had functional MR (atrial or ventricular type) and a “small” mitral annulus with an annular area ranging from 32 to 36 cm² (median 35 cm²), while the mean mitral valve area was 4.1 cm². Clinical and echocardiographic assessments were performed before the procedure, in the early postoperative period, and at 1-year follow-up in 16 patients (34.7%). The evaluation included mitral regurgitation (MR) severity, transmitral pressure gradient, left ventricular remodeling function, and the incidence of complications.
Results. Technical success of M-TEER was achieved in 44 of 46 patients (95.6%). Non-fatal in-hospital complications occurred in 3 patients (6.5%), and no procedure-related mortality was observed. In the early postoperative period, MR severity was reduced to ≤ grade 2 in 95.5% of patients; residual severe MR (grade 3) was present in only 4.5%, and no cases of grade 4 MR were recorded. The median mean transmitral gradient increased from 2 to 3 mmHg, remained within a low range, and did not differ between atrial and ventricular MR. At 1-year follow-up (n = 16), 75% of patients still had MR ≤ grade 2, with no cases of grade 4 MR. The mean transmitral gradient remained stable, and left ventricular ejection fraction was preserved or moderately improved, particularly in patients with ventricular MR. No evidence of progressive iatrogenic mitral stenosis was detected.
Conclusion. Transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus demonstrated high technical success, a low complication rate, and sustained reduction of mitral regurgitation while maintaining low transmitral gradients. M-TEER may be considered an effective and safe alternative to surgery in high-risk patients with borderline mitral valve area. However, such procedures should be performed in expert, high-volume specialized centers with extensive experience in transcatheter valvular interventions.
About the Authors
Elena Z. GolukhovaRussian Federation
Academician of the RAS, PhD, MD, Professor, Honored Scientist of the Russian Federation, Director of the Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Gulamzhan M. Dadabayev
Russian Federation
PhD, Research Fellow, Endovascular Diagnosis and Treatment Physician, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Baizak A. Sagymbayev
Russian Federation
Endovascular Diagnosis and Treatment Physician, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Inessa V. Slivneva
Russian Federation
PhD, Specialist in Ultrasound Diagnostics, Head of Cardiovascular Imaging and Innovative Technologies Group, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Marina Yu. Mironenko
Russian Federation
PhD, MD, Head of the Department of Ultrasound Diagnostics, Head of the Ultrasound Diagnostics Division, Ultrasound Diagnostics Physician, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Karen A. Ter-Akopian
Russian Federation
Physician-postgraduate in Endovascular Diagnosis and Treatment, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Arina M. Antonova
Russian Federation
Resident, Department of Ultrasound Diagnostics, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Karen V. Petrosian
Russian Federation
PhD, MD, Head of the Department of X-ray Surgical Diagnostics and Treatment of Heart and Vascular Diseases, Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
References
1. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999 Mar 15;83(6):897-902. doi: 10.1016/s0002-9149(98)01064-9. Erratum in: Am J Cardiol 1999 Nov 1;84(9):1143. PMID: 10190406.
2. Savage DD, Garrison RJ, Devereux RB, Castelli WP, Anderson SJ, Levy D, McNamara PM, Stokes J 3rd, Kannel WB, Feinleib M. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J. 1983 Sep;106(3):571-6. doi: 10.1016/0002-8703(83)90704-4. PMID: 6881031.
3. Enríquez-Sarano M, Schaff H, Orszulak T, et al. Mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2003;108(2):149-155. doi:10.1161/01.CIR.0000083831.17708.25.
4. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014 Jul 15;64(2):172-81. doi: 10.1016/j.jacc.2013.12.062. PMID: 25011722.
5. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean-François Obadia 1, David Messika-Zeitoun et al. N Engl J Med . 2018 Dec 13;379(24):2297-2306. doi: 10.1056
6. Stone GW, Abraham WT, Lindenfeld J, Kar S, Grayburn PA, Lim DS, Mishell JM, Whisenant B, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Asch FM, Mack MJ; COAPT Investigators. Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation. N Engl J Med. 2023 Jun 1;388(22):2037-2048. doi: 10.1056/NEJMoa2300213. Epub 2023 Mar 5. PMID: 36876756.
7. FDA IFU; FDA S-Supplement MitraClip Clip Delivery System – Summary of Safety and Effectiveness Data (PMA P100009) https://www.accessdata.fda.gov/cdrh_docs/pdf10/P100009c.pdf
8. Katz WE, Conrad Smith AJ, Crock FW, Cavalcante JL. Echocardiographic evaluation and guidance for MitraClip procedure. Cardiovasc Diagn Ther. 2017 Dec;7(6):616-632. doi: 10.21037/cdt.2017.07.04. PMID: 29302467; PMCID: PMC5752829.
9. Hausleiter J, Stocker TJ, Adamo M, Karam N, Swaans MJ, Praz F. Mitral valve transcatheter edge-to-edge repair. EuroIntervention. 2023 Jan 23;18(12):957-976. doi: 10.4244/EIJ-D-22-00725. PMID: 36688459; PMCID: PMC9869401.
10. von Bardeleben RS, Mahoney P, Morse MA, et al. 1-year outcomes with fourth-generation mitral valve transcatheter edge-to-edge repair from the EXPAND G4 study. J Am Coll Cardiol Intv. 2023;Epub ahead of print.
11. Kato Y, Okada A, Amaki M, Nishimura K, Kanzaki H, Kataoka Y, Miyamoto K, Hamatani Y, Amano M, Takahama H, Hasegawa T, Kusano K, Fujita T, Kobayashi J, Yasuda S, Izumi C. Three-dimensional echocardiography for predicting mitral stenosis after MitraClip for functional mitral regurgitation. J Echocardiogr. 2022 Sep;20(3):151-158. doi: 10.1007/s12574-022-00564-x. Epub 2022 Jan 27. PMID: 35084686.
12. Hussein, A, Waggoner, T. Transcatheter Edge-to-Edge Repair in Small Mitral Valve Area: Overcoming Anatomical Constraints. J Am Coll Cardiol Case Rep. 2025 Sep, 30 (27) . https://doi.org/10.1016/j.jaccas.2025.105134
13. Mushiake K, Kubo S, Ono S, Maruo T, Nishiura N, Osakada K, Kadota K, Yamamoto M, Saji M, Asami M, Enta Y, Nakashima M, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yamaguchi J, Izumi Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Otsuka T, Hayashida K; OCEAN-Mitral Investigators. Association of Baseline Mitral Valve Area With Procedural and Clinical Outcomes of Mitral Transcatheter Edge-to-Edge Repair: Insights From the OCEAN-Mitral Registry. Circ Cardiovasc Interv. 2024 Dec;17(12):e014420. doi: 10.1161/CIRCINTERVENTIONS.124.014420. Epub 2024 Dec 17. PMID: 39689186.
14. Enta Y, Saigan M, Munehisa Y, Ichikawa S, Yoshiyama K, Kosuga M, Maeda M, Teng Y, Satomi N, Kobayashi Y, Nakashima M, Toki Y, Miyasaka M, Hayatsu Y, Tada N. Unavoidable Iatrogenic Mitral Stenosis Following Transcatheter Edge-to-Edge Mitral Valve Repair With Current Devices. JACC Cardiovasc Interv. 2025 Feb 10;18(3):395-397. doi: 10.1016/j.jcin.2024.10.033. Epub 2024 Dec 18. PMID: 39708012.
Review
For citations:
Golukhova E.Z., Dadabayev G.M., Sagymbayev B.A., Slivneva I.V., Mironenko M.Yu., Ter-Akopian K.A., Antonova A.M., Petrosian K.V. EFFICACY OF TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH A 'NARROW' FIBROUS ANNULUS. Complex Issues of Cardiovascular Diseases. 2026;15(2):165-179. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-2-165-179
JATS XML

































